Stroke Prevention in Atrial Fibrillation.
Atrial fibrillation
Digital health
Left atrial appendage closure
Risk stratification
Stroke prevention
Wearable technology
Journal
Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
accepted:
12
09
2022
pubmed:
23
9
2022
medline:
15
12
2022
entrez:
22
9
2022
Statut:
ppublish
Résumé
Atrial fibrillation is associated with a significant increase in stroke and systemic embolism. This review explores the areas of stroke prevention. In the last decade, NOAC has overtaken warfarin as the anticoagulant of choice for stroke prevention in AF. For patients unable to take anticoagulation, LAA closure has proven to be a valid option. The use of digital devices has led to widespread consumer-directed AF screening. It remains to be determined if all device detect AF pose the same amount of risk as recent studies have shown that short and infrequent episodes of AF may not benefit from anticoagulation. Stroke prevention is paramount in the management of AF. In this review we describe the risk factors contributing to stroke, recent advances in antithrombotic therapies, and the increasing role of digital health in guiding AF detection and stroke prevention.
Identifiants
pubmed: 36136225
doi: 10.1007/s11886-022-01787-1
pii: 10.1007/s11886-022-01787-1
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1765-1774Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.